Marginalizing the genomic architecture to identify crosstalk across cancer and neurodegeneration
Front Mol Neurosci
.
2023 Feb 27:16:1155177.
doi: 10.3389/fnmol.2023.1155177.
eCollection 2023.
Authors
Amit Sharma
1
,
Ullrich Wüllner
2
,
Ingo G H Schmidt-Wolf
3
,
Jarek Maciaczyk
1
4
Affiliations
1
Department of Neurosurgery, University Hospital of Bonn, Bonn, Germany.
2
Department of Neurology, University Hospital of Bonn, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
3
Department of Integrated Oncology, Center for Integrated Oncology (CIO), University Hospital of Bonn, Bonn, Germany.
4
Department of Surgical Sciences, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
PMID:
36923654
PMCID:
PMC10008880
DOI:
10.3389/fnmol.2023.1155177
No abstract available
Keywords:
cancer; epigenome; genome; neurodegeneration; pathway.